S&P 500   3,958.75 (+0.63%)
DOW   33,800.56 (+0.60%)
QQQ   283.19 (+0.95%)
AAPL   142.63 (+1.20%)
MSFT   247.34 (+1.22%)
META   115.94 (+1.76%)
GOOGL   94.14 (-0.84%)
AMZN   89.89 (+1.62%)
TSLA   170.45 (-2.06%)
NVDA   167.71 (+4.04%)
NIO   13.21 (+5.01%)
BABA   93.37 (+5.71%)
AMD   70.22 (+0.11%)
T   19.18 (-0.62%)
MU   55.51 (+3.14%)
CGC   3.19 (-1.54%)
F   13.13 (+0.23%)
GE   83.34 (-1.95%)
DIS   92.67 (+0.56%)
AMC   6.25 (+3.31%)
PYPL   75.13 (+0.95%)
PFE   50.95 (+1.41%)
NFLX   307.49 (-0.30%)
S&P 500   3,958.75 (+0.63%)
DOW   33,800.56 (+0.60%)
QQQ   283.19 (+0.95%)
AAPL   142.63 (+1.20%)
MSFT   247.34 (+1.22%)
META   115.94 (+1.76%)
GOOGL   94.14 (-0.84%)
AMZN   89.89 (+1.62%)
TSLA   170.45 (-2.06%)
NVDA   167.71 (+4.04%)
NIO   13.21 (+5.01%)
BABA   93.37 (+5.71%)
AMD   70.22 (+0.11%)
T   19.18 (-0.62%)
MU   55.51 (+3.14%)
CGC   3.19 (-1.54%)
F   13.13 (+0.23%)
GE   83.34 (-1.95%)
DIS   92.67 (+0.56%)
AMC   6.25 (+3.31%)
PYPL   75.13 (+0.95%)
PFE   50.95 (+1.41%)
NFLX   307.49 (-0.30%)
S&P 500   3,958.75 (+0.63%)
DOW   33,800.56 (+0.60%)
QQQ   283.19 (+0.95%)
AAPL   142.63 (+1.20%)
MSFT   247.34 (+1.22%)
META   115.94 (+1.76%)
GOOGL   94.14 (-0.84%)
AMZN   89.89 (+1.62%)
TSLA   170.45 (-2.06%)
NVDA   167.71 (+4.04%)
NIO   13.21 (+5.01%)
BABA   93.37 (+5.71%)
AMD   70.22 (+0.11%)
T   19.18 (-0.62%)
MU   55.51 (+3.14%)
CGC   3.19 (-1.54%)
F   13.13 (+0.23%)
GE   83.34 (-1.95%)
DIS   92.67 (+0.56%)
AMC   6.25 (+3.31%)
PYPL   75.13 (+0.95%)
PFE   50.95 (+1.41%)
NFLX   307.49 (-0.30%)
S&P 500   3,958.75 (+0.63%)
DOW   33,800.56 (+0.60%)
QQQ   283.19 (+0.95%)
AAPL   142.63 (+1.20%)
MSFT   247.34 (+1.22%)
META   115.94 (+1.76%)
GOOGL   94.14 (-0.84%)
AMZN   89.89 (+1.62%)
TSLA   170.45 (-2.06%)
NVDA   167.71 (+4.04%)
NIO   13.21 (+5.01%)
BABA   93.37 (+5.71%)
AMD   70.22 (+0.11%)
T   19.18 (-0.62%)
MU   55.51 (+3.14%)
CGC   3.19 (-1.54%)
F   13.13 (+0.23%)
GE   83.34 (-1.95%)
DIS   92.67 (+0.56%)
AMC   6.25 (+3.31%)
PYPL   75.13 (+0.95%)
PFE   50.95 (+1.41%)
NFLX   307.49 (-0.30%)

Fresenius Medical Care AG & Co. KGaA - FMS Stock Forecast, Price & News

$15.99
+0.18 (+1.14%)
(As of 12/8/2022 12:08 PM ET)
Add
Compare
Today's Range
$15.79
$16.01
50-Day Range
$12.81
$16.38
52-Week Range
$12.78
$35.04
Volume
13,473 shs
Average Volume
803,861 shs
Market Capitalization
$9.37 billion
P/E Ratio
11.34
Dividend Yield
3.16%
Price Target
$38.16

Fresenius Medical Care AG & Co. KGaA MarketRank™ Forecast

Analyst Rating
Hold
1.89 Rating Score
Upside/​Downside
138.6% Upside
$38.16 Price Target
Short Interest
Healthy
0.24% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
-10.64%
From $1.41 to $1.26 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.34 out of 5 stars

Medical Sector

309th out of 1,027 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

3rd out of 8 stocks

FMS stock logo

About Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FMS Stock News Headlines

3 Stocks With Dividends of 3% or More to Buy on the Dip
Fresenius Medical's (FMS) Q3 Earnings and Revenues Top
10 Best European Dividend Stocks to Buy Now
FMS Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA (FMS)
See More Headlines
Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FMS Company Calendar

Last Earnings
10/30/2022
Today
12/08/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/28/2023

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Employees
122,909
Year Founded
1912

Price Target and Rating

Average Stock Price Forecast
$38.16
High Stock Price Forecast
$72.00
Low Stock Price Forecast
$17.10
Forecasted Upside/Downside
+138.6%
Consensus Rating
Hold
Rating Score (0-4)
1.89
Research Coverage
9 Analysts

Profitability

Net Income
$1.15 billion
Pretax Margin
6.95%

Debt

Sales & Book Value

Annual Sales
$20.85 billion
Cash Flow
$5.48 per share
Book Value
$28.22 per share

Miscellaneous

Free Float
N/A
Market Cap
$9.37 billion
Optionable
Optionable
Beta
1.06

Social Links


Key Executives

  • Mr. Robert Maurice Powell Jr. (Age 67)
    Chairman of the Management Board
    Comp: $3.38M
  • Ms. Helen Giza (Age 54)
    Deputy CEO, Chief Transformation Officer, CFO & Member of Mgmt Board of Fresenius Med. Care Mgmt AG
    Comp: $1.75M
  • Dr. Franklin W. Maddux F.A.C.P. (Age 65)
    Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG
    Comp: $1.56M
  • Mr. William J. Valle (Age 62)
    Management Board Member for Care Delivery of Fresenius Medical Care Management AG
    Comp: $3.85M
  • Dr. Katarzyna Mazur-Hofsab Ph.D. (Age 59)
    Management Board Member for Care Enablement of Fresenius Medical Care Management AG
    Comp: $4.29M
  • Mr. Roberto Fuste (Age 70)
    Exec. Advisor for Regional Strategy
  • Dr. Carla Kriwet (Age 51)
    CEO & Chair of the Management Board of Fresenius Medical Care
  • Dr. Nwamaka Eneanya M.D.
    Head of Strategy & Operations
  • Dr. Dominik Heger
    Exec. VP and Head of Investor Relations, Strategic Devel. & Communications
  • Mr. Borries Von Muller (Age 61)
    Sr. VP of Global HR Employee Communications













FMS Stock - Frequently Asked Questions

Should I buy or sell Fresenius Medical Care AG & Co. KGaA stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last twelve months. There are currently 2 sell ratings, 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares.
View FMS analyst ratings
or view top-rated stocks.

What is Fresenius Medical Care AG & Co. KGaA's stock price forecast for 2023?

9 brokerages have issued twelve-month target prices for Fresenius Medical Care AG & Co. KGaA's shares. Their FMS share price forecasts range from $17.10 to $72.00. On average, they predict the company's share price to reach $38.16 in the next twelve months. This suggests a possible upside of 141.4% from the stock's current price.
View analysts price targets for FMS
or view top-rated stocks among Wall Street analysts.

How have FMS shares performed in 2022?

Fresenius Medical Care AG & Co. KGaA's stock was trading at $32.46 at the beginning of the year. Since then, FMS shares have decreased by 51.3% and is now trading at $15.81.
View the best growth stocks for 2022 here
.

Are investors shorting Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 1,390,000 shares, an increase of 103.9% from the October 31st total of 681,600 shares. Based on an average trading volume of 1,260,000 shares, the days-to-cover ratio is presently 1.1 days.
View Fresenius Medical Care AG & Co. KGaA's Short Interest
.

When is Fresenius Medical Care AG & Co. KGaA's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 28th 2023.
View our FMS earnings forecast
.

How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) issued its earnings results on Sunday, October, 30th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.37 by $0.03. The business earned $5.14 billion during the quarter, compared to the consensus estimate of $4.60 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.01% and a trailing twelve-month return on equity of 6.03%.

How often does Fresenius Medical Care AG & Co. KGaA pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA declared an annual dividend on Friday, April 29th. Investors of record on Monday, May 16th will be paid a dividend of $0.7093 per share on Friday, May 27th. This represents a dividend yield of 3.4%. The ex-dividend date of this dividend is Friday, May 13th.
Read our dividend analysis for FMS
.

Is Fresenius Medical Care AG & Co. KGaA a good dividend stock?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) pays an annual dividend of $0.49 per share and currently has a dividend yield of 3.16%. The dividend payout ratio is 34.75%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 38.89% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FMS.

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).

What is Fresenius Medical Care AG & Co. KGaA's stock symbol?

Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

Who are Fresenius Medical Care AG & Co. KGaA's major shareholders?

Fresenius Medical Care AG & Co. KGaA's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Pzena Investment Management LLC (2.24%), Fiduciary Management Inc. WI (1.04%), Tweedy Browne Co LLC (0.17%), Two Sigma Investments LP (0.09%), BlackRock Inc. (0.07%) and Two Sigma Advisers LP (0.07%).

How do I buy shares of Fresenius Medical Care AG & Co. KGaA?

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fresenius Medical Care AG & Co. KGaA's stock price today?

One share of FMS stock can currently be purchased for approximately $15.81.

How much money does Fresenius Medical Care AG & Co. KGaA make?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has a market capitalization of $9.27 billion and generates $20.85 billion in revenue each year. The company earns $1.15 billion in net income (profit) each year or $1.41 on an earnings per share basis.

How many employees does Fresenius Medical Care AG & Co. KGaA have?

The company employs 122,909 workers across the globe.

Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries?
The following companies are subsidiares of Fresenius Medical Care AG & Co. KGaA: NxStage Medical.
Read More
How can I contact Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The official website for the company is www.freseniusmedicalcare.com. The company can be reached via phone at (496) 172-6090, via email at ir@fmc-ag.com, or via fax at 49-6172-609-2301.

This page (NYSE:FMS) was last updated on 12/8/2022 by MarketBeat.com Staff